• Diabetes is the leading cause of end-stage kidney disease in Indigenous Australians, a population at particularly high risk of diabetes and chronic kidney disease.
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Melbourne, and iohexol measured using a validated HPLC assay modified from NiculescuDuvaz et al. [14, 17] .
Measurement of enzymatic creatinine
Serum creatinine was measured in venous blood collected 120 minutes following iohexol injection. Creatinine was measured by a single laboratory (Melbourne Pathology, Melbourne Australia) using the Roche enzymatic assay. This method had traceability to isotope-dilution mass spectrometry as claimed by the manufacturer and supported by independent studies [18] . Thirteen participants for whom a centralised creatinine result was unavailable were excluded from this analysis.
Estimates of GFR (eGFR)
Estimates of GFR were calculated as using the previously described MDRD, CKD-EPI and (where Scr is serum creatinine concentration in μmol/l, age in years, eGFR in ml min -1 1.73 m -2 ).
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absolute differences. Confidence intervals were calculated using the binomial exact method for proportions. 
Results

Participants
In total, 656 Indigenous Australians were recruited to the study. Of these participants, 65
were excluded as they did not have measured GFR, 13 were excluded as they did not have available data for centralized enzymatic creatinine, 13 were excluded because they were less than 18 years of age, and one person was excluded because diabetes status was not able to be determined. Accordingly, 564 Indigenous participants had complete data for this analysis:
224 with diabetes (40%) and 340 without diabetes (Table 1) . Participants with diabetes were shorter and had a greater BMI, waist circumference and waist-hip ratio, as well as a higher
Accepted Article
frequency of microalbuminuria and macroalbuminuria. There were fewer smokers in participants with diabetes, and participants with diabetes were on average 12 years older than participants without diabetes.
Participants with diabetes had a lower measured/estimated GFR than participants without diabetes, although they also had a greater spread of GFR ( 
CKD-EPI vs. MDRD
The performance of the CKD-EPI and the MDRD formulas in participants with or without diabetes is illustrated in Fig. 1 and summarized in Table 2 . For participants with or without diabetes, the CKD-EPI formula performed better than the MDRD formula. In both participants with and without diabetes, the CKD-EPI formula had a smaller bias and greater accuracy than the MDRD formula overall, as well as for the eGFR< 90 and eGFR > 90 ml min -1 1.73 m -2 groups. Figure 1 shows that the CKD-EPI formula had a smaller bias than the MDRD formula for participants without diabetes and eGFR between 40 and 110 ml min -1 1.73 m -2 , as well as for participants with diabetes and eGFR between 30 and
There was a greater range of the mGFR, CKD-EPI eGFR and MDRD eGFR in Indigenous
Australians with diabetes than in those without diabetes ( 
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Bias and accuracy of the CKD-EPI formula
Overall, the CKD-EPI formula underestimated the measured GFR by 7.0 ml min 
Cockcroft-Gault formula
The performance of the Cockcroft-Gault formula is illustrated in Fig. 2 and presented in Table 2 . For all participants, the Cockcroft-Gault formula overestimated mGFR (ml/min) by 9.9 ml/min, with no difference in performance for those with or without diabetes. The
Cockcroft-Gault formula performed well for participants both with and without diabetes at levels of < 90 ml/min, with a smaller bias but reduced accuracy for participants with diabetes compared with those without diabetes when Cockcroft-Gault was < 90 ml/min.
Discussion
There is a large burden of Type 
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Cockcroft-Gault formulas. The CKD-EPI formula had a smaller bias, at least for eGFR in the range 40-110 ml min -1 1.73 m -2 and had a greater accuracy than the MDRD and Cockcroft-Gault formulas. These findings in Indigenous Australians largely concur with the findings of the CKD-EPI study [4] , which showed that the CKD-EPI formula had a smaller bias than the MDRD formula for people with diabetes in the groups with eGFR < 60/60-90/≥ 90 ml min -1 1.73 m -2 , and also for people without diabetes in the groups with eGFR < 60/60-90 ml min -1 1.73 m -2 . However, our findings also support the findings of Camargo et al., who similarly found that the CKD-EPI formula was less accurate in people with Type 2 diabetes when compared with healthy individuals [7] . The study by Camargo et al. was a small study of 56 patients with Type 2 diabetes and 55 healthy volunteers from a single centre. Furthermore, in that study, creatinine was measured using the Jaffe reaction and, unlike the enzymatic method used in the present study, may be prone to interference from plasma glucose [25] .
For participants with or without diabetes, the relationship between bias and eGFR level in our study using the CKD-EPI formula was broadly similar to that of the CKD-EPI study. In the CKD-EPI study, the bias was also greater in those with diabetes compared with those without diabetes. In people with diabetes, the CKD-EPI formula underestimated measured GFR by [4] . Likewise, when our data were evaluated across the whole eGFR range, the bias was greater in Indigenous Australians with diabetes than in those without diabetes (7.0 vs. 3.5 ml min -1 1.73 m -2 , respectively), and this was a consistent finding in the > 90 ml min -1 1.73 m -2 subgroup. Despite this, the performance of the CKD-EPI formula was superior to that of the MDRD and CockcroftGault formulas in people with and without diabetes, reinforcing the recommended use of the CKD-EPI formula in people with diabetes [3, 11] .
Participants with diabetes had a lower measured GFR and CKD-EPI eGFR than those without diabetes. Hence, it may be impossible to determine the effect of 'diabetes' status per se on the formulas, as it is often difficult to match participants in terms of their diabetes status and other characteristics essential for the formulas. Indeed, we observed a greater range of mGFR in those with diabetes compared with those without diabetes. At the higher end of mGFR, it is likely that this is an effect of hyperfiltration in people with diabetes [26] . Indeed, a recent assessment of 15 creatinine-based formulas in 600 participants with Type 2 diabetes questioned the use of any formula to identify hyperfiltration and monitor progression of kidney disease in those with Type 2 diabetes without overt nephropathy [27] .
The strengths of the current study include the measurement of GFR using iohexol clearance, the relatively large number of participants in the high GFR range, the presence of a similar
future studies are necessary in these high-risk populations, in people with and without diabetes, to determine rates and predictors of progression of chronic kidney disease and the clinical utility of the CKD-EPI formula for predicting kidney function loss over time.
The limitations of the study are recognized. Research studies have reported a GFR measurement error of 5-20% variation within a single clearance procedure or between clearance procedures on different days [30, 31] . The variation is greater in the higher ranges of GFR on the absolute scale [31] . Furthermore, hydration status and hyperglycaemia can routinely affect the measurement of GFR. Whilst the GFR can be determined precisely by measuring the clearance of inulin [32], the measurement using iohexol is more practical in real-world settings, particularly in remote locations. Another limitation in the current study has also been alluded to by Stevens et al. and relates to the populations in which the formulas were derived [6] . There may have been selection bias in those who volunteered to participate in this study; that is, healthier people may choose to participate in studies such as this in general. Furthermore, in the current study, the participants were asked not to have a proteinbased meal prior to their non-fasting blood test, which would have minimized the impact of dietary variations, which may have influenced measured creatinine. Creatinine levels can also be affected by drugs [33, 34] , including the commencement of angiotensin-converting enzyme inhibitors [35] ; however, no specific medication changes were made before participation in this study.
In summary, the CKD-EPI formula outperforms the MDRD and Cockcroft-Gault formulas overall in Indigenous Australians with and without diabetes. However, the CKD-EPI formula has a greater bias in people with diabetes compared with those without diabetes, especially in those with normal renal function.
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This article is protected by copyright. All rights reserved. Bias and % bias are median (95% CI), Precision is interquartile range of the bias (25th, 75th percentile of the bias), Accuracy is % of eGFR within 30% of reference GFR (95% CI). '% < -30%' is the % of eGFR below 30% of reference GFR, '% > 30%' is the % of eGFR above 30% of reference GFR.
Bias is (mGFR-eGFR); % bias is the median percentage difference relative to mGFR; and precision is the interquartile range of the absolute differences.
P-values were calculated using the Mann-Whitney U-test for bias and % bias, interquantile range regression for precision, χ 2 -test for accuracy.
